Loading...
XNYS
RELX
Market cap58bUSD
Sep 11, Last price  
33.80USD
1D
-0.06%
1Q
0.18%
Jan 2017
88.09%
Name

Relx PLC

Chart & performance

D1W1MN
XNYS:RELX chart
P/E
21.12
P/S
4.55
EPS
1.18
Div yield, %
2.56%
Shrs. gr., 5y
-0.99%
Rev. gr., 5y
6.17%
Revenues
9.59b
+1.65%
2,385,261,0002,424,936,0002,821,686,0003,211,559,0003,203,095,0003,175,058,0006,116,000,0006,035,000,0005,773,000,0005,971,000,0006,895,000,0007,355,000,0007,492,000,0007,874,000,0007,110,000,0007,244,000,0008,553,000,0009,161,000,0009,434,000,0009,590,000,000
Net income
2.07b
+6.77%
298,905,000848,252,000172,411,000177,724,000261,346,000290,548,0001,069,000,0001,110,000,000955,000,0001,008,000,0001,161,000,0001,659,000,0001,422,000,0001,505,000,0001,224,000,0001,471,000,0001,634,000,0001,781,000,0001,934,000,0002,065,000,000
CFO
2.88b
+10.28%
585,000,000829,000,000-11,000,000-8,000,000-5,000,000-3,000,0001,407,000,0001,386,000,0001,377,000,0001,407,000,0001,682,000,0001,848,000,0001,985,000,0002,089,000,0001,596,000,0002,016,000,0002,401,000,0002,457,000,0002,608,000,0002,876,000,000
Dividend
Aug 07, 20260.27851 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Headquartered in London, United Kingdom, and established in 1903, RELX PLC (which rebranded from Reed Elsevier PLC in July 2015) offers sophisticated information analytics and decision-support tools to professional and business clientele across North America, Europe, and other international markets. Its operations are organized into four distinct divisions. The Risk division specializes in delivering analytics and decision systems that blend public and industry-specific data with advanced technology and algorithms, enabling clients to evaluate and anticipate various risks. The Scientific, Technical & Medical segment furnishes essential information and analytical insights to institutions and professionals, facilitating scientific advancement and improvements in healthcare. Within the Legal segment, the company supplies legal, regulatory, and commercial information and analytics, empowering customers' decision-making processes and enhancing their productivity. Lastly, the Exhibitions segment manages events, integrating in-person experiences with data and digital technologies to assist clients in understanding markets, identifying products, and closing deals.

Related entities

Subsidiaries (53)
LEXISNEXIS BUSINESS INFORMATION SOLUTIONS
LEXISNEXIS BUSINESS INFORMATION SOLUTIONS B.V.
LexisNexis Business Information Solutions Holding
LexisNexis GmbH
LexisNexis Information Technology Co., Ltd.
LEXISNEXIS RISK SOLUTIONS (EUROPE) LIMITED
LexisNexis Risk Solutions FL Inc.
LEXISNEXIS RISK SOLUTIONS UK LIMITED
LEXISNEXIS SA
LEXISNEXIS SERVICOS DE ANALISE DE RISCO LTDA.
LEXISNEXIS UNIVENTIO B.V.
LNRS Data Services (Shanghai) Co. Ltd
LNRS DATA SERVICES B.V.
LNRS DATA SERVICES INC.
LNRS DATA SERVICES LIMITED
MLEX LIMITED
Reed Elsevier Shared Services (Philippines) Inc.
REED EXHIBITIONS ALCANTARA MACHADO LTDA
REED EXHIBITIONS MEXICO SA DE CV
REED INTERNATIONAL BOOKS AUSTRALIA PTY LIMITED

Key people

Chief Executive Officer, Executive Director · since 2009
Chairwoman, RELX Technology Forum and President, Exhibitions Europe · since 2016
Chief Executive Officer - Exhibitions · since 2015
Director - Corporate Affairs and Chairman Elsevier · since 2011
Chief Human Resource Officer · since 2017
Chief Strategy Officer · since 2016
Non-Executive Independent Director · since 2019
Non-Executive Independent Director · since 2016
Non-Executive Independent Director · since 2012
Non-Executive Independent Director · since 2017
IPO date
Apr 21, 1948
Employees
33,200
Domiciled in
GB
Incorporated in
GB
Headquarters & legal address
1-3 STRAND
LONDON, LND WC2N 5JR
GB
Previous name
REED ELSEVIER PLC

Valuation

Title
GBP in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT